The global market for In Vitro Diagnostics (IVD) Quality Control was valued at USD 84.7 billion in 2020, and is expected to register a CAGR of 19.30% during the forecast period. The steady growth is attributed to rising prevalence of chronic diseases, such as diabetes and cancer, increasing prevalence of cardiovascular diseases (CVDs), growing demand for advanced and rapid diagnostic systems, and escalating demand for third-party IVD quality controls.


In vitro diagnostics quality control refers to assessment of the overall performance of IVD tests, and is widely used to identify defects and maintain the quality of IVD tests. The use of IVD quality controls conforms to ISO 9001 quality standards and regulations, and is monitored through government inspections, independent audits, and post-market surveillance.


Get a free sample PDF of the report, visit @


The growth of the global market is majorly supported by several advantages associated with IVD quality control, such as sensitive and long-term monitoring of IVD test systems performances, multiple-level quality control analysis, and identification of critical analytical system issues.


However, the lack of technical expertise in quality control and assessment of IVD devices may restrain the market growth going ahead. The global in vitro diagnostics quality control market is segmented into immunochemistry, clinical chemistry, molecular diagnostics, hematology, coagulation & hemostasis, microbiology, and others. The immunochemistry segment accounted for the largest share of the global market in 2020, and is predicted to register the highest growth in revenue over the forecast period.


North America dominates the global market in terms of revenue and is expected to display the fastest revenue growth rate over the forecast period. The market growth in this region is accelerated by the rapid spread of infectious diseases such as urinary tract infection, increasing patient pool, rising number of accredited clinical laboratories and diagnostic centers, and growing awareness about early disease diagnosis in the region.


To know more about the latest insights of the report, visit @


Some of the key market players in the global in vitro diagnostics quality control market include Abbott Laboratories Inc., Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Siemens Healthineers, Randox Laboratories Ltd., Technopath Clinical Diagnostics, Fortress Diagnostics, Roche Diagnostics, Bio-Techne Corporation, Danaher Corporation, SeraCare Life Sciences Inc., Ortho-Clinical Diagnostics, Inc., Sysmex Corporation, and Helena Laboratories. These market players have been undertaking various strategic initiatives, such as mergers & acquisitions, collaborations, joint ventures, and new business deals, to strengthen their market positions.


In conclusion, the global in vitro diagnostics quality control market is expected to experience significant growth in the coming years, driven by the rising prevalence of chronic diseases, increasing demand for advanced and rapid diagnostic systems, and escalating demand for third-party IVD quality controls. However, the lack of technical expertise in quality control and assessment may restrain market growth to some extent.


Request customization of the report @


Thank you for reading our report. Please connect with us to know more about the report and its customization feature. Our team will ensure the report is well suited to meet your requirements.


About Reports and Data 


Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behaviour shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.


John W, Head of Business Development
Reports And Data | Web:
Direct Line: +1-212-710-1370
LinkedIn | Twitter | Blogs


Browse for more reports…